ASCEND2.0, a commercialization initiative overseen by the New Mexico Start-Up Factory (NMSUF), is proud to announce the launch of Tozho LLC, a pioneering new biotech company emerging from research supported by the Idaho ASCEND2.0 program.

Tozho LLC is developing a novel targeted drug delivery technology that utilizes a specialized carrier to transport therapeutics directly to specific locations in the body—offering transformative potential for precision medicine and improved patient outcomes.

The company, led by John Chavez, Managing Director of NMSUF, works to accelerate the path from research to market through entrepreneurial support and investment. As a collaborator assisting for non-dilutive funding, Dr. Ching-An Peng created the Tozho technology, but he is not part of the company.

“This is exactly the kind of translational science ASCEND2.0 was designed to support,” said John Chavez, managing director of NMSUF. “Tozho represents how regionally rooted research can scale into national impact.”

The launch of Tozho highlights the success of ASCEND2.0 in fostering biotech innovation in underserved regions like Idaho and underscores NMSUF’s role in turning early-stage technologies into investable, high-impact companies.

Learn more about the Tozho team and technology here.